How to start a peptide telehealth brand, step by step

Which peptides can you actually sell?

Two groups. The six in the HHS enforcement discretion policy of October 30, 2026: BPC-157, TB-500, Epitalon, KPV, MOTS-c and Semax, each as a single-ingredient compounded product in a named form. And the peptide drugs that are FDA approved and sold as the approved product: semaglutide, tirzepatide, tesamorelin and bremelanotide among them.

Everything else stays off the shelf. That includes every blend, Selank, ipamorelin, CJC-1295, AOD-9604, DSIP, injectable GHK-Cu and LL-37. A supplier's price list that carries them is not a reason to sell them. Start with two or three products, not twelve. Every product is an intake to maintain and a set of state rules to keep right.

What do you need before the store?

An entity and a lawyer. Most states have corporate practice of medicine and fee-splitting rules that decide who may own the clinical side and how money flows between the brand and the clinician. This is the question to pay a healthcare lawyer for, and the answer is different in California, Texas and New York.

A prescriber. Every peptide order is a patient-specific prescription. Either you contract clinicians licensed in each state you sell into, or you use a provider network that covers 50 states and lets the clinician decide independently. Independence is not a formality. A clinician who cannot decline is not a clinician a regulator will accept.

A 503A pharmacy with its paperwork. Ask for the supplier qualification record for each peptide, the certificate of analysis for the current lot, the labeling, and the adverse event procedure. Confirm which forms it makes and that each matches a permitted route. If you already have a pharmacy you trust, it can be routed to through Surescripts. If not, start with the platform's partners.

Policies. Privacy, terms, telehealth consent, a BAA with every vendor that touches patient data, and a refund policy that says what happens when a clinician declines.

How should the store be built?

One product per peptide, one intake per product. The intake asks what the clinician needs to decide, including the questions that screen out the patients who should not have it. The questionnaire for a nasal spray is not the questionnaire for an injectable.

State rules on every product. The store knows where each product can be sold and refuses the visit before the patient pays.

Subscriptions that match the prescription. A peptide prescribed in intermittent courses, as the policy names for Epitalon, should not be on a subscription that never pauses. Set the cadence to how it is actually prescribed, and require a fresh intake before a renewal where the clinician wants one.

No claims. The product page describes the product, says it is compounded and not FDA approved, and shows safety information. It does not say what it will do for the patient. A compliance check that reads your pages for outcome language before you publish is worth having, and the platform runs one.

An off switch. Unpublishing a product and telling its subscribers should take a day, because the policy is interim.

How do you price it?

From cost up, not from a competitor's price list down. Your cost per order is the clinician's visit fee, the medication and the pharmacy's dispensing and shipping, and your payment processor's rate. The platform is a flat monthly fee with nothing per order. Put those on one line and price above it with the margin you need after ads, which are the largest line for most brands.

The pharmacy's price to you decides most of this, and prices differ a lot between pharmacies for the same vial. Get two quotes. Make sure a quote is what the pharmacy charges you, not a patient price list.

Multi-month shipments reduce per-order costs, since one shipment carries one dispensing fee and one shipping charge, but only where the prescriber is willing to write that supply.

How do you market it without getting banned?

Google and Meta treat prescription products as restricted. Expect to need a certification such as LegitScript before ads for prescription products run, and expect ads that name a peptide to be refused regardless. Most peptide brands grow through content, email, referral and organic search, which is slower and durable.

Every claim you make about a peptide is yours to substantiate under FTC rules, and there is no published trial to lean on. Say what the product is and let the clinician say what it is for. What your store can and cannot say goes through it line by line.

What does the launch look like?

Three states, two products, one pharmacy. Run ten real orders through the whole chain: intake, clinician decision, prescription, pharmacy, shipping, tracking, first renewal. Watch where a patient gets stuck. Then add states, then products.

On Dispense Flow the store, the intake, the provider network and the pharmacy routing are already wired. What takes time is your entity, your lawyer and your pharmacy's paperwork, and all of that runs while the store is being built.